Dual HER2-targeting without chemotherapy and estrogen deprivation in the neoadjuvant setting

Por Sikov, William M.
Publicado em 2014

Clinical utility of the combination of lapatinib and letrozole in the management of hormone receptor-positive and HER2-positive advanced breast cancer

Por Merriam, Priscilla, Sikov, William M
Publicado em 2011

Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study

Por Schumacher, Andrew, Sikov, William M., Quesenberry, Matthew I., Safran, Howard, Khurshid, Humera, Mitchell, Kristen M., Olszewski, Adam J.
Publicado no PLoS One (2017)

Impact of Race, Ethnicity and BMI on Achievement of Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer: A Pooled Analysis of Four Prospective Allianc...

Por Warner, Erica T., Ballman, Karla V., Strand, Carrie, Boughey, Judy, Buzdar, Aman U., Carey, Lisa A., Sikov, William M., Partridge, H.
Publicado no Breast Cancer Res Treat (2016)

Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer

Por Brodsky, Alexander S., Xiong, Jinjun, Yang, Dongfang, Schorl, Christoph, Fenton, Mary Anne, Graves, Theresa A., Sikov, William M., Resnick, Murray B., Wang, Yihong
Publicado no BMC Cancer (2016)

Impact of Neoadjuvant Chemotherapy in Stage II–III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates: Surgical Results From C...

Por Golshan, Mehra, Cirrincione, Constance T., Sikov, William M., Berry, Donald A., Jasinski, Sara, Weisberg, Tracey F., Somlo, George, Hudis, Clifford, Winer, Eric, Ollila, David W.
Publicado no Ann Surg (2015)

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)

Por Golshan, Mehra, Cirrincione, Constance T., Sikov, William M., Carey, Lisa A., Berry, Donald A., Overmoyer, Beth, Henry, Nora L., Somlo, George, Port, Elisa, Burstein, Harold J., Hudis, Clifford, Winer, Eric, Ollila, David W.
Publicado no Breast Cancer Res Treat (2016)

Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Resp...

Por Sikov, William M., Berry, Donald A., Perou, Charles M., Singh, Baljit, Cirrincione, Constance T., Tolaney, Sara M., Kuzma, Charles S., Pluard, Timothy J., Somlo, George, Port, Elisa R., Golshan, Mehra, Bellon, Jennifer R., Collyar, Deborah, Hahn, Olwen M., Carey, Lisa A., Hudis, Clifford A., Winer, Eric P.
Publicado no J Clin Oncol (2015)